Tscan Therapeutics, Inc. · NASDAQ:TCRX
BlackRock, Inc.'s stake in Tscan Therapeutics, Inc. fell to 1.80% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc.'s stake in Tscan Therapeutics, Inc. fell to 1.80%, 958,373 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 1.80%
- Shares
- 958,373
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.80% | 958,373 |
Source
Related
- Tscan Therapeutics, Inc.
- BlackRock, Inc.
- Tscan Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2025
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026